Vera stock dropped after Otsuka announced plans for accelerated approval of sibeprenlimab. Learn why VERA stock is a Hold.

Arrowhead Pharmaceuticals, Inc. today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company's investigational RNA interference (RNAi) therapeutic designed to ...

Arrowhead Pharmaceuticals’ phase 1/2a study has found the company’s investigational RNA interference (RNAi) candidate was ...

Novak Djokovic and Naomi Osaka are among the stars who were bounced at the BNP Paribas Open. Here’s what it means for their seasons and careers.

Patients with IgA nephropathy (IgAN ... ARO-C3 is designed to reduce hepatocyte production of complement component 3 (C3) as a potential treatment for various complement mediated renal diseases.

H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line ...

Select Phase 1/2 Study Results Patients with IgA nephropathy (IgAN ... About ARO-C3 ARO-C3 is designed to reduce hepatocyte production of complement component 3 (C3) as a potential treatment ...

Arrowhead (ARWR) announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference ...

In the United States, Irish whiskey has long been overshadowed by bourbon and Scotch whisky. Where those styles have enjoyed ...

Discover how your body and mind adapt when sexual activity stops, from changing desire patterns to unexpected effects on your ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...

Discover how laughter naturally improves lung health by enhancing oxygen flow, clearing airways, and boosting respiratory ...